相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。The role of Hippo/yes-associated protein signalling in vascular remodelling associated with cardiovascular disease
Jinlong He et al.
BRITISH JOURNAL OF PHARMACOLOGY (2018)
The cancer theory of pulmonary arterial hypertension
Olivier Boucherat et al.
PULMONARY CIRCULATION (2017)
Control of Proliferation and Cancer Growth by the Hippo Signaling Pathway
Ursula Ehmer et al.
MOLECULAR CANCER RESEARCH (2016)
HIPPO-Integrin-linked Kinase Cross-Talk Controls Self-Sustaining Proliferation and Survival in Pulmonary Hypertension
Tatiana V. Kudryashova et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2016)
Mechanisms of Hippo pathway regulation
Zhipeng Meng et al.
GENES & DEVELOPMENT (2016)
Vascular stiffness mechanoactivates YAP/TAZ-dependent glutaminolysis to drive pulmonary hypertension
Thomas Bertero et al.
JOURNAL OF CLINICAL INVESTIGATION (2016)
ACE2 overexpression inhibits acquired platinum resistance-induced tumor angiogenesis in NSCLC
Qijian Cheng et al.
ONCOLOGY REPORTS (2016)
Pharmacological targeting of kinases MST1 and MST2 augments tissue repair and regeneration
Fuqin Fan et al.
SCIENCE TRANSLATIONAL MEDICINE (2016)
Combination therapy versus monotherapy for pulmonary arterial hypertension: a meta-analysis
Annie Christine Lajoie et al.
LANCET RESPIRATORY MEDICINE (2016)
Angiotensin-Converting Enzyme 2 Attenuates Bleomycin-Induced Lung Fibrosis in Mice
Lifang Wang et al.
CELLULAR PHYSIOLOGY AND BIOCHEMISTRY (2015)
Angiotensin-(1-7) Suppresses Hepatocellular Carcinoma Growth and Angiogenesis via Complex Interactions of Angiotensin II Type 1 Receptor, Angiotensin II Type 2 Receptor and Mas Receptor
Yanping Liu et al.
MOLECULAR MEDICINE (2015)
Angiotensin-converting enzyme 2/angiotensin-(1-7)/Mas axis prevents lipopolysaccharide-induced apoptosis of pulmonary microvascular endothelial cells by inhibiting JNK/NF-κB pathways
Yingchuan Li et al.
SCIENTIFIC REPORTS (2015)
Matrix Remodeling Promotes Pulmonary Hypertension through Feedback Mechanoactivation of the YAP/TAZ-miR-130/301 Circuit
Thomas Bertero et al.
CELL REPORTS (2015)
Mammalian Target of Rapamycin Complex 2 ( mTORC2) Coordinates Pulmonary Artery Smooth Muscle Cell Metabolism, Proliferation, and Survival in Pulmonary Arterial Hypertension
Dmitry A. Goncharov et al.
CIRCULATION (2014)
The Hippo pathway is controlled by Angiotensin II signaling and its reactivation induces apoptosis in podocytes
D. O. Wennmann et al.
CELL DEATH & DISEASE (2014)
Cell cycle dependence of ACE-2 explains downregulation in idiopathic pulmonary fibrosis
Bruce D. Uhal et al.
EUROPEAN RESPIRATORY JOURNAL (2013)
ACE2 Activation Confers Endothelial Protection and Attenuates Neointimal Lesions in Prevention of Severe Pulmonary Arterial Hypertension in Rats
Gang Li et al.
LUNG (2013)
Regulation of the Hippo-YAP Pathway by G-Protein-Coupled Receptor Signaling
Fa-Xing Yu et al.
CELL (2012)
β-Catenin-Driven Cancers Require a YAP1 Transcriptional Complex for Survival and Tumorigenesis
Joseph Rosenbluh et al.
CELL (2012)
Angiotensin-converting enzyme 2 activation protects against pulmonary arterial hypertension through improving early endothelial function and mediating cytokines levels
Li Gang et al.
CHINESE MEDICAL JOURNAL (2012)
ACE2, a promising therapeutic target for pulmonary hypertension
Vinayak Shenoy et al.
CURRENT OPINION IN PHARMACOLOGY (2011)
Hippo signaling: growth control and beyond
Georg Halder et al.
DEVELOPMENT (2011)
ACCF/AHA 2011 Expert Consensus Document on Hypertension in the Elderly A Report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents Developed in Collaboration With the American Academy of Neurology, American Geriatrics Society, American Society for Preventive Cardiology, American Society of Hypertension, American Society of Nephrology, Association of Black Cardiologists, and European Society of Hypertension
Wilbert S. Aronow et al.
JOURNAL OF THE AMERICAN SOCIETY OF HYPERTENSION (2011)
Strategic Plan for Lung Vascular Research An NHLBI-ORDR Workshop Report
Serpil Erzurum et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2010)
Evidence for Angiotensin-converting Enzyme 2 as a Therapeutic Target for the Prevention of Pulmonary Hypertension
Anderson J. Ferreira et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2009)
Connective Tissue Growth Factor Confers Drug Resistance in Breast Cancer through Concomitant Up-regulation of Bcl-xL and cIAP1
Ming-Yang Wang et al.
CANCER RESEARCH (2009)
Prevention of Pulmonary Hypertension by Angiotensin-Converting Enzyme 2 Gene Transfer
Yoriko Yamazato et al.
HYPERTENSION (2009)
Endothelial cells and pulmonary arterial hypertension: apoptosis, proliferation, interaction and transdifferentiation
Seiichiro Sakao et al.
RESPIRATORY RESEARCH (2009)
Tumor suppressor LATS1 is a negative regulator of oncogene YAP
Yawei Hao et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
Inactivation of YAP oncoprotein by the Hippo pathway is involved in cell contact inhibition and tissue growth control
Bin Zhao et al.
GENES & DEVELOPMENT (2007)
The nuclear factor of activated T cells in pulmonary arterial hypertension can be therapeutically targeted
Sebastien Bonnet et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
The key role of apoptosis in the pathogenesis and treatment of pulmonary hypertension
Emin Gurbanov et al.
EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY (2006)
Endothelial-mesenchymal transition occurs during embryonic pulmonary artery development
E Arciniegas et al.
ENDOTHELIUM-JOURNAL OF ENDOTHELIAL CELL RESEARCH (2005)
Gene therapy targeting survivin selectively induces pulmonary vascular apoptosis and reverses pulmonary arterial hypertension
MS McMurtry et al.
JOURNAL OF CLINICAL INVESTIGATION (2005)
Simvastatin rescues rats from fatal pulmonary hypertension by inducing apoptosis of neointimal smooth muscle cells
T Nishimura et al.
CIRCULATION (2003)
分享论文
